Pre-intervention in 2011 (n = 52) | Post-intervention in 2012 (n = 52) | p-value | |
---|---|---|---|
Antipsychotic | |||
dose (mg) | 982.6 (200.0–2395.1) | 857.6 (75.0–2418.6) | p < 0.001 |
No. of medicine(s) | 2.0 (1.0–6.0) | 2.0 (1.0–5.0) | p = 0.025 |
Concurrent agent n (%) | |||
anti-Parkinson | 25 (48.1) | 24 (46.2) | p = 0.500 |
benzodiazepine | 42 (80.8) | 38 (73.1) | p = 0.243 |
mood stabilizer | 28 (53.8) | 30 (57.5) | p = 0.423 |
Seclusion room use n (%) | 23 (44.2) | 15 (28.8) | p = 0.077 |
Cost (USD) | |||
all medicine | 10.33 (1.33–104.79) | 8.76 (0.45–34.16) | p = 0.045 |
antipsychotic | 8.04 (0.25–32.47) | 6.48 (0.25–33.66) | p = 0.016 |
psychotropic | 9.42 (0.25–64.12) | 7.68 (0.25–34.05) | p = 0.004 |